Malaria Diagnostics Market Research, 2026
The global malaria diagnostics market accounted for $728,870 thousand in 2018 and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.
Malaria is an infection caused by parasites, which is highly fatal if left untreated. This infectious diseases spreads through the bite of infected female Anopheles mosquito. The bite leads to transfer of plasmodium parasites into the human body. In addition, there are different types of plasmodium parasites such as Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi. Furthermore, these parasites lodge into liver cells where they multiply and grow. These parasites then move to red blood cells to reach a stage called merozoites where they grow inside the red cells and kill them. The loss of red blood cells causes symptoms such as fever, tiredness, vomiting and headaches. In addition, the procedures and examinations that are conducted to identify malarial infection are called as malaria diagnostics. There are different types of malaria diagnostic available in the market for such as rapid diagnostic tests, microscopy, and molecular diagnostic tests.
The major factor that contributes to the growth of the malaria diagnostics market include rise in prevalence of malaria in developing countries. Furthermore, surge in awareness initiatives by governments and increase in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.
Malaria Diagnostics Market Segmentation
The malaria diagnostics market is studied on the basis of product type, end user, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. By end user, it is bifurcated into hospital, clinics, and diagnostic centers. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA).
Product Type Segment Review
According to product type, rapid diagnostic tests acquired the major share of the malaria diagnostics market in 2018, owing to benefits associated with the use of RDTs in the diagnosis of malaria. For instance, RDTs are inexpensive, simple to operate and read, highly sensitive & specific, stable at high temperatures, and provide results in shorter period of time. Therefore, contribute to the growth of malaria diagnostic tests market. Furthermore, the molecular diagnostic tests segment is expected to grow at the fastest pace during the forecast period, owing to high specificity associated with the use of the test, which can lead to better treatment outcomes. In addition, rise in awareness among people regarding early diagnosis of malaria for better treatment supplements the growing demand for malaria diagnostic tests.
By Product Type
Rapid Diagnostic Tests is projected as one of the most lucrative segment.
End User Segment Review
By end user, the clinics segment acquired the major share of the malaria diagnostics market, owing to surge in number of clinics worldwide. In addition, diagnostic centers are expected to exhibit the fastest growth rate during the forecast period due to surge in awareness related to early diagnosis of malaria infection for better treatment.
By End User
Clinics holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
Region-wise Segment Review
By region, LAMEA accounted for the major malaria diagnostics market share in 2018, and is expected to continue this trend, owing to rapid surge in prevalence of malaria in the region. Moreover, widespread of the malaria vector, Anopheles gambiae, which is difficult to control, in the region is another major factor that leads to surge in cases of malaria. Furthermore, majority of malarial infections in the region are caused by the most lethal type of malarial parasite called as Plasmodium falciparum. Therefore, there is a need for early diagnosis of malaria infection in this region, which boosts the growth of the market. In addition, malaria infection is endemic to some parts of Africa, which leads to the growth of the market in the region. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, attributed to the increase in awareness regarding the use of malaria diagnostics for early diagnosis of the infection for better treatment. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as the constant development leads to surge in awareness related to the use of malaria diagnostics.
By Geography
Asia-Pacific region would exhibit the highest CAGR of 6.1% during 2019-2026.
Key Benefits for Stakeholders:
- This report entails a detailed quantitative analysis along with the current global malaria diagnostics market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The malaria diagnostics market forecast is studied from 2019 to 2026.
- The malaria diagnostics market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Malaria Diagnostics Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By END USER |
|
 By Region |
|
 Key Market Players | Access Bio. Inc., Atlas Medical, BIOMÉRIEUX SA, Abbott Laboratories, SIEMENS, Olympus Corporation, Bio-Rad Laboratories, Inc., NOVARTIS AG, Meridian Bioscience Inc., Premier Medical Corporation Pvt Ltd. |
Analyst Review
Malaria diagnostics are defined as tests and procedures which are used in the identification and of malarial infection. These diagnostics are used extensively as the infection is highly prevalent and fatal. Furthermore, malaria is caused by the bite of female Anopheles mosquito, which leads to transfer of malarial parasites that destroy the blood cells of the host. This leads to critical symptoms such as impaired consciousness, multiple convulsions, abnormal bleeding, and signs of anemia, fever, and chills and others. Therefore, there are different types of malaria diagnostics which are used to identify the infection such as rapid diagnostic tests, microscopy, and molecular diagnostic tests.
The utilization of malaria diagnostics has witnessed a significant growth, owing to surge in prevalence of malaria across the globe. Furthermore, other factors that contribute to the growth of the market include the surge in healthcare expenditure, rise in research related to new malaria diagnostics, and rise in initiatives by governments towards eradication of malaria.
The total market value of malaria diagnostics market is $728,870.4 thousand in 2018.
The forcast period for malaria diagnostics market is 2019 to 2026
The market value of malaria diagnostics market in 2019 is $766,042.8 thousand
The base year is 2018 in malaria diagnostics market
Top companies such as, Premier Medical Corporation Pvt Ltd., Access Bio. Inc., Abbott Laboratories, Biomérieux SA, and Bio-Rad Laboratories, Inc held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
Rapid diagnostic tests (RDTs) segment is the most influencing segment oeing to benefits associated with the use of RDTs in diagnosis of malaria also boosts the market growth. For instance, RDTs are inexpensive, simple to operate and read, highly sensitive & specific, stable at high temperatures, and provide results in shorter period of time
The major factor that fuels the growth of the malaria diagnostics market include the surge in prevalence of malaria across the globe. This leads to surge in the demand for malaria diagnostics which boots the growth of the market.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 6.1%. This is due to highly populated countries in the region such as China and India which have the potential to offer a huge patient base of malaria.
Malaria diagnostics are defined as tests and procedures which are employed in the confirmation of presence of malaria parasite in the blood. Furthermore, there are different types of malaria diagnostics which are offered in the market such as rapid diagnostic tests, molecular diagnostic tests and others.
Malaria diagnostics are employed for checking the presence of malaria causing parasite in the blood. Furthemore, these diagnostics also provide analysis about the stage of diseases which is important in treatment of the condition
Loading Table Of Content...
